{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:06:16Z","timestamp":1789553176262,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd007578","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T00:00:00Z","timestamp":1300233600000}}],"reference-count":395,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007578.pub2","type":"journal-article","created":{"date-parts":[[2011,3,9]],"date-time":"2011-03-09T18:06:02Z","timestamp":1299693962000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Notification and support for people exposed to the risk of Creutzfeldt-Jakob disease (CJD) (or other prion diseases) through medical treatment (iatrogenically)"],"prefix":"10.1002","volume":"2011","author":[{"given":"Rebecca","family":"Ryan","sequence":"first","affiliation":[{"name":"Australian Institute for Primary Care & Ageing, La Trobe University; Centre for Health Communication and Participation; Bundoora VIC Australia 3086"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Hill","sequence":"additional","affiliation":[{"name":"Australian Institute for Primary Care & Ageing, La Trobe University; Centre for Health Communication and Participation; Bundoora VIC Australia 3086"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne","family":"Lowe","sequence":"additional","affiliation":[{"name":"Australian Institute for Primary Care & Ageing, La Trobe University; Centre for Health Communication and Participation; Bundoora VIC Australia 3086"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Allen","sequence":"additional","affiliation":[{"name":"Southern Health; Centre for Clinical Effectiveness (CCE); Locked Bag 29 Clayton Victoria Australia 3168"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Taylor","sequence":"additional","affiliation":[{"name":"La Trobe University; Australian Institute for Primary Care & Ageing, Faculty of Health Sciences; Bundoora VIC Australia 3086"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Mead","sequence":"additional","affiliation":[{"name":"La Trobe University; Australian Institute for Primary Care & Ageing, Faculty of Health Sciences; Bundoora VIC Australia 3086"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,3,16]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0001|cit1","first-page":"25","article-title":"Risk communication, risk perception, and public health","volume":"103","author":"Aakko","year":"2004","journal-title":"Wisconsin Medical Journal"},{"issue":"7417","key":"10.1002\/14651858.CD007578.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/bmj.327.7417.728","article-title":"How can doctors communicate information about risk more effectively?","volume":"327","author":"Alaszewski","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0003|cit3","volume-title":"Report of the inquiry into the use of pituitary derived hormones in Australia and Creutzfeldt-Jakob disease","author":"Allars","year":"June 1994"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0004|cit4","unstructured":"Parliament of Australia Senate Report on the CJD Settlement Offer October 1997"},{"issue":"6596","key":"10.1002\/14651858.CD007578.pub2-BIB0005|cit5","first-page":"115","article-title":"Award for information on BSE","volume":"383","author":"Anonymous","year":"1996","journal-title":"Nature"},{"issue":"9041","key":"10.1002\/14651858.CD007578.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0140-6736(96)21049-9","article-title":"Betraying the public over nvCJD risk","volume":"348","author":"Anonymous","year":"1996","journal-title":"Lancet"},{"issue":"6606","key":"10.1002\/14651858.CD007578.pub2-BIB0007|cit7","first-page":"206","article-title":"Europe reviews CJD surveillance","volume":"384","author":"Anonymous","year":"1996","journal-title":"Nature"},{"issue":"17","key":"10.1002\/14651858.CD007578.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/jama.1996.03530410017009","article-title":"World Health Organization consultation on public health issues related to bovine spongiform encephalopathy and the emergence of a new variant of Creutzfeldt-Jakob disease","volume":"275","author":"Anonymous","year":"1996","journal-title":"JAMA"},{"issue":"11","key":"10.1002\/14651858.CD007578.pub2-BIB0009|cit9","first-page":"6","article-title":"Human tissue used in graft: hospital has duty to heed warnings on packaging and to investigate source of tissue","volume":"4","author":"Anonymous","year":"1996","journal-title":"Legal Eagle Eye Newsletter for the Nursing Profession"},{"issue":"5","key":"10.1002\/14651858.CD007578.pub2-BIB0010|cit10","first-page":"453","article-title":"Public health issues and clinical and neurological characteristics of the new variant of Creutzfeldt-Jakob disease and other human and animal transmissible spongiform encephalopathies: Memorandum from two WHO meetings","volume":"74","author":"Anonymous","year":"1996","journal-title":"Bulletin of the World Health Organization"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0011|cit11","first-page":"12","article-title":"CJD infection linked to dura mater grafts... Creutzfeldt-Jakob disease","volume":"25","author":"Anonymous","year":"1998","journal-title":"Hospital Infection Control"},{"issue":"9157","key":"10.1002\/14651858.CD007578.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(99)00048-3","article-title":"Tragedy of variant Creutzfeldt-Jakob disease [comment]","volume":"353","author":"Anonymous","year":"1999","journal-title":"Lancet"},{"issue":"2170","key":"10.1002\/14651858.CD007578.pub2-BIB0013|cit13","first-page":"3","article-title":"Choose ignorance: we need to know what we're up against with human BSE, but not at any price","volume":"161","author":"Anonymous","year":"1999","journal-title":"New Scientist"},{"issue":"4","key":"10.1002\/14651858.CD007578.pub2-BIB0014|cit14","first-page":"386","article-title":"Guidelines to follow in the case of sexually transmitted risk","volume":"7","author":"Anonymous","year":"2000","journal-title":"Transfusion Clinique et Biologique"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/bjo.84.2.129","article-title":"nvCJD and contact lenses","volume":"84","author":"Anonymous","year":"2000","journal-title":"British Journal of Ophthalmology"},{"issue":"20","key":"10.1002\/14651858.CD007578.pub2-BIB0016|cit16","first-page":"1","article-title":"Exposure to Creutzfeldt-Jakob Disease","volume":"June 1","author":"Anonymous","year":"2001","journal-title":"Sentinel Event Alert"},{"issue":"9","key":"10.1002\/14651858.CD007578.pub2-BIB0017|cit17","first-page":"117","article-title":"A mad, mad world: ICPs fight panic with policy for much misunderstood CJD: but patient-to-patient transmission can occur","volume":"28","author":"Anonymous","year":"2001","journal-title":"Hospital Infection Control"},{"issue":"10","key":"10.1002\/14651858.CD007578.pub2-BIB0018|cit18","first-page":"446","article-title":"FDA and HHS move to combat BSE-vCJD","volume":"18","author":"Anonymous","year":"2001","journal-title":"Infections in Medicine"},{"issue":"6","key":"10.1002\/14651858.CD007578.pub2-BIB0019|cit19","first-page":"45","article-title":"Hospitalisations and fatalities from notifiable communicable diseases in 2000","volume":"8","author":"Anonymous","year":"2001","journal-title":"New Zealand Public Health Report"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0020|cit20","first-page":"165","article-title":"From nannyism to public disclosure: The BSE inquiry report","volume":"164","author":"Anonymous","year":"2001","journal-title":"CMAJ"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0021|cit21","first-page":"I","article-title":"Former surgical patients at Ontario hospital warned of \"remote\" CJD risk","volume":"33","author":"Anonymous","year":"2001","journal-title":"Clinical Infectious Diseases"},{"issue":"9","key":"10.1002\/14651858.CD007578.pub2-BIB0022|cit22","first-page":"122","article-title":"CJD instruments: track down, destroy, or sterilize: policy prevents reuse on subsequent patients","volume":"28","author":"Anonymous","year":"2001","journal-title":"Hospital Infection Control"},{"issue":"9","key":"10.1002\/14651858.CD007578.pub2-BIB0023|cit23","first-page":"123","article-title":"Guidelines for suspected CJD cases in the operating room","volume":"28","author":"Anonymous","year":"2001","journal-title":"Hospital Infection Control"},{"issue":"9","key":"10.1002\/14651858.CD007578.pub2-BIB0024|cit24","first-page":"120","article-title":"Mad cows & Englishmen: variant CJD emerges in UK: CDC looking, but no cases seen yet in U.S","volume":"28","author":"Anonymous","year":"2001","journal-title":"Hospital Infection Control"},{"issue":"4","key":"10.1002\/14651858.CD007578.pub2-BIB0025|cit25","first-page":"37","article-title":"Stay out of the headlines: ensure proper sterilization of instruments: 2 incidents raise question: could you spread diseases to other patients?","volume":"25","author":"Anonymous","year":"2001","journal-title":"Same-Day Surgery"},{"issue":"4","key":"10.1002\/14651858.CD007578.pub2-BIB0026|cit26","first-page":"1","article-title":"Self-study series, lesson no. 63, April 2002: Creutzfeldt-Jakob Disease","volume":"26","author":"Anonymous","year":"2002","journal-title":"Healthcare Purchasing News"},{"issue":"3","key":"10.1002\/14651858.CD007578.pub2-BIB0027|cit27","first-page":"90","article-title":"Infectology - Yesterday, today and tomorrow","volume":"22","author":"Anonymous","year":"2002","journal-title":"Infektoloski Glasnik"},{"issue":"5","key":"10.1002\/14651858.CD007578.pub2-BIB0028|cit28","first-page":"67","article-title":"CJD 'nightmare' leads to routine high sterilization: a staggering 3,600 patients notified","volume":"30","author":"Anonymous","year":"2003","journal-title":"Hospital Infection Control"},{"issue":"3","key":"10.1002\/14651858.CD007578.pub2-BIB0029|cit29","first-page":"226","article-title":"Eight questions consumers should ask on the threat of BSE... bovine spongiform encephalopathy","volume":"43","author":"Anonymous","year":"2003","journal-title":"Journal of Advanced Nursing"},{"issue":"36","key":"10.1002\/14651858.CD007578.pub2-BIB0030|cit30","first-page":"8","article-title":"DoH to warn blood recipients of CJD risk","volume":"100","author":"Anonymous","year":"2004","journal-title":"Nursing Times"},{"issue":"10","key":"10.1002\/14651858.CD007578.pub2-BIB0031|cit31","first-page":"130","article-title":"Australian hospital warns of possible CJD exposure: more than 1,000 patients contacted","volume":"31","author":"Anonymous","year":"2004","journal-title":"Hospital Infection Control"},{"issue":"11","key":"10.1002\/14651858.CD007578.pub2-BIB0032|cit32","first-page":"32","article-title":"Emory hospital notifies patients following CJD case","volume":"20","author":"Anonymous","year":"2004","journal-title":"OR Manager"},{"issue":"33","key":"10.1002\/14651858.CD007578.pub2-BIB0033|cit33","first-page":"9","article-title":"Behind the headlines. 'Professor warns of vCJD timebomb'","volume":"100","author":"Anonymous","year":"2004","journal-title":"Nursing Times"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0034|cit34","first-page":"20","article-title":"Expanded \"mad cow\" safeguards announced to strengthen existing firewalls","volume":"February 22","author":"Anonymous","year":"2004","journal-title":"Medical Letter on the CDC and FDA"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0035|cit35","first-page":"1","article-title":"Fighting the good fight in Europe","volume":"6","author":"Anonymous","year":"2005","journal-title":"Nature Immunology"},{"issue":"9","key":"10.1002\/14651858.CD007578.pub2-BIB0036|cit36","first-page":"18","article-title":"Next stage of notification exercise to reduce risk of variant CJD transmission begins","volume":"2","author":"Anonymous","year":"2005","journal-title":"Journal of Operating Department Practice"},{"issue":"179","key":"10.1002\/14651858.CD007578.pub2-BIB0037|cit37","first-page":"14","article-title":"Notification exercise begins to reduce risk of vCJD transmission","volume":"August\/Septembe","author":"Anonymous","year":"2005","journal-title":"Operating Theatre Journal"},{"issue":"7518","key":"10.1002\/14651858.CD007578.pub2-BIB0038|cit38","first-page":"652","article-title":"In brief","volume":"331","author":"Anonymous","year":"2005","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0039|cit39","first-page":"E060209.2","article-title":"New case of transfusion-associated vCJD in the United Kingdom [erratum]","volume":"11","author":"Anonymous","year":"2006","journal-title":"Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles [European Communicable Disease Bulletin]"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0040|cit40","first-page":"91","article-title":"Tissue infectivity and transmissible spongiform encephalopathies","volume":"20","author":"Anonymous","year":"2006","journal-title":"WHO Drug Information"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007578.pub2-BIB0041|cit41","first-page":"26","article-title":"Implications of emerging pathogens in the management of haemophilia","volume":"12","author":"Anonymous","year":"2006","journal-title":"Haemophilia"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0042|cit42","first-page":"58","article-title":"Practice matters. Take note: research news, clinical and practice updates, drug alerts, healthcare legislation, and more","volume":"1","author":"Anonymous","year":"2006","journal-title":"American Nurse Today"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD007578.pub2-BIB0043|cit43","first-page":"3","article-title":"Statements on epidemiology","volume":"33","author":"Anonymous","year":"2006","journal-title":"Transfusion Medicine & Hemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0044|cit44","first-page":"8","article-title":"In brief","volume":"8","author":"Anonymous","year":"2007","journal-title":"British Journal of Infection Control"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0045|cit45","first-page":"8","article-title":"Prion removal technique gives vCJD hope","volume":"8","author":"Anonymous","year":"2007","journal-title":"British Journal of Infection Control"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0046|cit46","unstructured":"Anonymous No white flags; the story of Helen Ferry, a sporadic CJD sufferer. Available at: CJD Support Group Network http:\/\/www.cjdsupport.net (accessed 13 March 2008)"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0047|cit47","unstructured":"Anonymous A Brief History Available at: CJD Support Group Network, http:\/\/www.cjdsupport.net\/index.php?sid=21 (accessed 13 March 2008)"},{"issue":"5544","key":"10.1002\/14651858.CD007578.pub2-BIB0048|cit48","first-page":"34","article-title":"Data briefing. BSE, CJD and cost-benefit analysis","volume":"107","author":"Appleby","year":"1997","journal-title":"Health Service Journal"},{"issue":"Suppl A","key":"10.1002\/14651858.CD007578.pub2-BIB0049|cit49","first-page":"4","article-title":"The role of clinicians in the detection of an epidemic","volume":"33","author":"Armengaud","year":"2003","journal-title":"Medecine et Maladies Infectieuses"},{"issue":"3","key":"10.1002\/14651858.CD007578.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1086\/527514","article-title":"Is surgery a risk factor for Creutzfeldt-Jakob disease? Outcome variation by control choice and exposure assessments","volume":"29","author":"Barash","year":"2008","journal-title":"Infection Control & Hospital Epidemiology"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2934.2005.00449.x","article-title":"Care management of Creutzfeldt-Jakob disease within the United Kingdom","volume":"13","author":"Barnett","year":"2005","journal-title":"Journal of Nursing Management"},{"issue":"3","key":"10.1002\/14651858.CD007578.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/019262339101900314","article-title":"Bovine spongiform encephalopathy and related agents: Risk factors of biological products. An informal consultation\/working meeting","volume":"19","author":"Baron","year":"1991","journal-title":"Toxicologic Pathology"},{"issue":"6735","key":"10.1002\/14651858.CD007578.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/20792","article-title":"Scientists must bridge the communication gap","volume":"399","author":"Battey","year":"1999","journal-title":"Nature"},{"issue":"7417","key":"10.1002\/14651858.CD007578.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/bmj.327.7417.725","article-title":"Communication and miscommunication of risk: understanding UK parents' attitudes to combined MMR vaccination [see comment]","volume":"327","author":"Bellaby","year":"2003","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1057\/palgrave.jors.2601899","article-title":"Assessing the risk of vCJD transmission via surgery: models for uncertainty and complexity","volume":"56","author":"Bennett","year":"2005","journal-title":"Journal of the Operational Research Society"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.tmrv.2003.12.006","article-title":"Proceedings of a consensus conference: the screening of blood donors for variant CJD","volume":"18","author":"Blajchman","year":"2004","journal-title":"Transfusion Medicine Reviews"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD007578.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1741-6892.2004.00442.x","article-title":"Implications of notifying donors and recipients","volume":"87","author":"Hewitt","year":"2004","journal-title":"Vox Sanguinis"},{"issue":"4","key":"10.1002\/14651858.CD007578.pub2-BIB0058|cit58","first-page":"177","article-title":"Lyodura use and the risk of iatrogenic Creutzfeldt-Jakob disease in Australia","volume":"180","author":"Brooke","year":"2004","journal-title":"MJA"},{"issue":"4 Suppl 9","key":"10.1002\/14651858.CD007578.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0037-1963(01)90130-1","article-title":"Creutzfeldt-Jakob disease: Blood infectivity and screening tests","volume":"38","author":"Brown","year":"2001","journal-title":"Seminars in Hematology"},{"issue":"4","key":"10.1002\/14651858.CD007578.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1537-2995.2001.41040433.x","article-title":"Transfusion medicine and spongiform encephalopathy","volume":"41","author":"Brown","year":"2001","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0061|cit61","first-page":"27","article-title":"Pathogenesis and transfusion risk of transmissible spongiform encephalopathies","volume":"120","author":"Brown","year":"2005","journal-title":"Developments in Biologicals"},{"issue":"6604","key":"10.1002\/14651858.CD007578.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/384008a0","article-title":"Brussels inquiry criticizes BSE secrecy","volume":"384","author":"Butler","year":"1996","journal-title":"Nature"},{"issue":"6602","key":"10.1002\/14651858.CD007578.pub2-BIB0063|cit63","first-page":"658","article-title":"CJD variant stirs debate on release of data","volume":"383","author":"Butler","year":"1996","journal-title":"Nature"},{"issue":"6606","key":"10.1002\/14651858.CD007578.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/384201b0","article-title":"BSE meeting reflects growing distrust of expert panels [comment]","volume":"384","author":"Butler","year":"1996","journal-title":"Nature"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1192\/apt.7.1.50","article-title":"Creutzfeldt-Jakob disease and its implications for psychiatric management","volume":"7","author":"Butler","year":"2001","journal-title":"Advances in Psychiatric Treatment"},{"issue":"5","key":"10.1002\/14651858.CD007578.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1046\/j.1537-2995.1999.39050540.x","article-title":"Creutzfeldt-Jakob disease targeted lookback","volume":"39","author":"Callum","year":"1999","journal-title":"Transfusion"},{"issue":"9327","key":"10.1002\/14651858.CD007578.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0140-6736(02)09421-7","article-title":"Communication of risk: Choice, consent, and trust","volume":"360","author":"Calman","year":"2002","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD007578.pub2-BIB0068|cit68","first-page":"179","article-title":"A survey of transfusion practice related to informed consent and post transfusion notification","volume":"63","author":"Carruthers","year":"2001","journal-title":"Canadian Journal of Medical Laboratory Science"},{"issue":"10","key":"10.1002\/14651858.CD007578.pub2-BIB0069|cit69","first-page":"1389","article-title":"Notifying patients exposed to blood products associated with Creutzfeldt-Jakob disease: Integrating science, legal duties and ethical mandates","volume":"157","author":"Caulfield","year":"1997","journal-title":"CMAJ"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0070|cit70","unstructured":"Commonwealth Department of Health and Family Services (Australia) HPH Newsletter Survey of pituitary hormone recipients Outlined in March 1995 newsletter; results reported in June 1995 issue"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0071|cit71","unstructured":"Commonwealth Department of Health and Family Services (Australia) HPH Newsletter Summary report of survey of recipients Outlined in October 1995 newsletter (preliminary results); summary of main results reported March 1996 newsletter"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0072|cit72","unstructured":"Cegelka J Creutzfeldt Jakob disease: the psychological effect it has on caregivers PhD thesis. The Union Institute and University Graduate College 2002"},{"issue":"6905","key":"10.1002\/14651858.CD007578.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/419326a","article-title":"BSE in human tissue fires debate on patient disclosure","volume":"419","author":"Check","year":"2002","journal-title":"Nature"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0074|cit74","unstructured":"CJD Incidents Panel Management of possible exposure to CJD through medical procedures, Framework Document, August 2005 www.hpa.org.uk\/infections\/topics_az\/cjd\/ (accessed 8 October 2007)"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0075|cit75","unstructured":"CJD Incidents Panel Fourth Annual Report (1 September 2003 to 31 August 2004) to the Advisory Committee on Dangerous Pathogens Working Group on Transmissible Spongiform Encephalopathies www.hpa.org.uk\/infections\/topics_az\/cjd\/incidents_panel.htm (accessed 13 March 2008)"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0076|cit76","unstructured":"CJD Incidents Panel CJD Incidents Panel Public summary of the 15th meeting 11h May 2005 www.camr.org.uk\/infections\/topics_az\/cjd\/summary05_05.pdf (accessed 8 October 2007)"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0077|cit77","unstructured":"CJD Incidents Panel Fifth Annual Report 1 September 2004 to 31 December 2005 to the Advisory Committee on Dangerous Pathogens Working Group on Transmissible Spongiform Encephalopathies www.hpa.org.uk\/infections\/topics_az\/cjd\/incidents_panel.htm (accessed 8 October 2007)"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0078|cit78","unstructured":"CJD Incidents Panel Sixth Annual Report 1 January to 31 December 2006 to the Advisory Committee on Dangerous Pathogens Working Group on Transmissible Spongiform Encephalopathies (http:\/\/www.hpa.org.uk\/infections\/topics_az\/cjd\/incidents_panel.htm) (accessed 4 March 2008)"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0079|cit79","unstructured":"CJD Incidents Panel Health Protection Agency Chief Dental Officer Advice note concerning problems with dental care for individuals 'at-risk' of CJD for public health purposes www.hpa.org.uk\/webw\/HPAweb&Page&HPAwebAutoListName\/Page\/1191942152869?p=1191942152869 (accessed 17 March 2008)"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0080|cit80","unstructured":"Chief Dental Officer Information for dentists about the management of patients with, or 'at-risk' of, Creutzfeldt-Jakob Disease (CJD) including variant CJD (vCJD) www.hpa.org.uk\/web\/HPAweb&HPAwebStandard\/HPAweb_C\/1195733840924 (accessed 17 March 2008)"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0081|cit81","unstructured":"Management Committee CJD Support Group Network CJD SGN Management response to Infection Control Guidelines for cCJD Obtained from CJD SGN"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0082|cit82","unstructured":"CJD Support Group Network Infection control issues, discrimination and refusal of treatment medical and dental - state by state. [data collected 1 June 2006 to 31 December 2006] Available from CJD SGN"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0083|cit83","unstructured":"CJD Support Group Network Issues for 'at risk of CJD' patients. 30 June 2006 Available from CJD SGN"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0084|cit84","unstructured":"CJD Support Group Network Infection control issues, discrimination and refusal of treatment medical and dental - state by state. [data collected 1 January 2007 to 30 June 2007] Available from CJD SGN"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0085|cit85","unstructured":"CJD Support Group Network Infection control issues, discrimination and refusal of treatment medical and dental - state by state. [data collected 1 July 2007 to 31 December 2007] Available from CJD SGN"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0086|cit86","unstructured":"CJD Support Group Network Understanding CJD Educational DVD Launched February 2008, Canberra Australia"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0087|cit87","first-page":"10","article-title":"Tissue banking (Creutzfeldt-Jakob disease): CJD-contaminated grafts may place recipients at risk for up to 16 years","author":"Clark","year":"1997","journal-title":"Health Letter on the CDC"},{"issue":"6","key":"10.1002\/14651858.CD007578.pub2-BIB0088|cit88","first-page":"43","article-title":"Cross infection of Creutzfeldt-Jakob disease","volume":"96","author":"Clarkson","year":"2000","journal-title":"Nursing Times"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0089|cit89","first-page":"51","article-title":"Variant Creutzfeldt-Jakob disease: a summary of current scientific knowledge in relation to public health","volume":"165","author":"Coulthart","year":"2001","journal-title":"CMAJ"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0181-5512(04)96087-1","article-title":"A screening questionnaire for determining risk of Creuzfeldt-Jacob disease transmission during ophthalmic examination","volume":"27","author":"Creuzot-Garcher","year":"2004","journal-title":"Journal Francais D'Ophtalmologie"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0091|cit91","first-page":"3","article-title":"Ask the ethicist: would you tell the patients?","volume":"Spring","author":"Culver","year":"2000","journal-title":"Medical Ethics"},{"issue":"6","key":"10.1002\/14651858.CD007578.pub2-BIB0092|cit92","first-page":"44","article-title":"Creutzfeld-Jakob disease: what we know","volume":"5","author":"Darlington","year":"1996","journal-title":"Leadership in Health Services"},{"issue":"2170","key":"10.1002\/14651858.CD007578.pub2-BIB0093|cit93","first-page":"5","article-title":"Testing times ahead -- if you were incubating \"human BSE\", would you want to know?","volume":"161","author":"Day","year":"1999","journal-title":"New Scientist"},{"issue":"3","key":"10.1002\/14651858.CD007578.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/096973309600300308","article-title":"Bovine spongiform encephalopathy (BSE): the ethics concerning decisions about whether to continue taking a risk with this disease [see comment]","volume":"3","author":"Dealler","year":"1996","journal-title":"Nursing Ethics"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0095|cit95","unstructured":"Department of Health and Aged Care Surveillance and Management Section National Centre for Disease Control Evaluation of the CJD Support Group Network Inc Final report, March 2001"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0096|cit96","unstructured":"Victorian Government Department of Human Services Report of the consensus workshop Creutzfeldt-Jakob disease: preventing transmission in the health care setting. Implementing the Infection Control Guidelines June 2005 (revised 2006) www.health.vic.gov.au\/ideas\/infcon (accessed 5 February 2008)"},{"issue":"7","key":"10.1002\/14651858.CD007578.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/nm0798-752a","article-title":"British MRC reprimanded over clinical test record","volume":"4","author":"Dickson","year":"1998","journal-title":"Nature Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007578.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2516.2006.01196.x","article-title":"Clinical implications of emerging pathogens in haemophilia: the variant Creutzfeldt-Jakob experience","volume":"12","author":"Dolan","year":"2006","journal-title":"Haemophilia"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0099|cit99","unstructured":"Douglas MJ Campbell H Will RG Patients with new variant Creutzfeldt-Jakob disease and their families: care and information needs 1999 http:\/\/www.cjd.ed.ac.uk\/carerep.html (accessed August 30 2007)"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1748-720X.1997.tb01394.x","article-title":"Creutzfeldt-Jakob disease - the problem of recipient notification","volume":"25","author":"Duval","year":"1997","journal-title":"Journal of Law, Medicine & Ethics"},{"issue":"11","key":"10.1002\/14651858.CD007578.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/jme.2005.011965","article-title":"Ethical considerations in presymptomatic testing for variant CJD","volume":"31","author":"Duncan","year":"2005","journal-title":"Journal of Medical Ethics"},{"issue":"7417","key":"10.1002\/14651858.CD007578.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/bmj.327.7417.691","article-title":"Communicating risks","volume":"327","author":"Edwards","year":"2003","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD007578.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1046\/j.1365-2516.1998.440628.x","article-title":"Prions and haemophilia - assessment of risk","volume":"4","author":"Evatt","year":"1998","journal-title":"Haemophilia"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0104|cit104","unstructured":"Farrell vs CSL Limited and Commonwealth of Australia At Supreme Court of Melbourne, at Common Law Division\u00a0Date of judgment: 26\u00a0August 2004"},{"issue":"3","key":"10.1002\/14651858.CD007578.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1046\/j.1365-2516.2002.00618.x","article-title":"Risk of variant Creuzfeldt-Jakob disease from factor concentrates: Current perspectives","volume":"8","author":"Farrugia","year":"2002","journal-title":"Haemophilia"},{"issue":"4","key":"10.1002\/14651858.CD007578.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1423-0410.2005.00702.x","article-title":"Variant Creutzfeldt-Jakob disease transmission by plasma products: assessing and communicating risk in an era of uncertainty","volume":"89","author":"Farrugia","year":"2005","journal-title":"Vox Sanguinis"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0107|cit107","unstructured":"Food Drug Administration Department of Health and Human Services Meeting of the Transmissable Spongiform Encephalopathies Committee, 18 September 2006 www.fda.gov\/ohrms\/dockets\/ac\/cber06.html#TransmissibleSpongiform (accessed 21 March 2008)"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0108|cit108","unstructured":"Food Drug Administration Department of Health and Human Services\u00a0 Meeting of the Transmissable Spongiform Encephalopathies Committee, 19 September 2006 www.fda.gov\/ohrms\/dockets\/ac\/cber06.html#TransmissibleSpongiform (accessed 21 March 2008)"},{"issue":"3","key":"10.1002\/14651858.CD007578.pub2-BIB0109|cit109","first-page":"247","article-title":"Creutzfeldt-Jakob disease and blood transfusion","volume":"98","author":"Fernandez Lopez","year":"1998","journal-title":"Acta Neurologica Belgica"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0196-6553(98)70065-3","article-title":"Prevention of Creutzfeldt-Jakob disease in health care workers: A case study","volume":"26","author":"Fishman","year":"1998","journal-title":"American Journal of Infection Control"},{"issue":"7037","key":"10.1002\/14651858.CD007578.pub2-BIB0111|cit111","first-page":"1037","article-title":"Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. Scientists who inflame public anxieties must share responsibility for resulting panic [comment]","volume":"312","author":"Fitzpatrick","year":"1996","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1467-9248.2004.00483.x","article-title":"Making a crisis out of a drama: The political analysis of BSE policy-making in the UK","volume":"52","author":"Forbes","year":"2004","journal-title":"Political Studies"},{"issue":"3","key":"10.1002\/14651858.CD007578.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0955-3886(97)00047-7","article-title":"Potential Creutzfeldt-Jakob disease (CJD) exposure: to notify or not to notify","volume":"18","author":"Freedman","year":"1997","journal-title":"Transfusion Science"},{"issue":"3","key":"10.1002\/14651858.CD007578.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/13698570310001606969","article-title":"Temporal stability of the psychological determinants of trust: implications for communication about food risks","volume":"5","author":"Frewer","year":"2003","journal-title":"Health, Risk & Society"},{"issue":"41","key":"10.1002\/14651858.CD007578.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"20","DOI":"10.7748\/ns.10.41.20.s33","article-title":"Getting the message across","volume":"10","author":"Galloway","year":"1996","journal-title":"Nursing Standard"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0116|cit116","first-page":"174","article-title":"Bovine spongiform encephalopathy: Risk, science and governance","volume":"61","author":"Giovannini","year":"2007","journal-title":"Journal of Epidemiology and Community Health"},{"issue":"3","key":"10.1002\/14651858.CD007578.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/jama.280.3.292","article-title":"Peer-reviewed articles and public health. The mad cow affair in Italian newspapers","volume":"280","author":"Girardi","year":"1998","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1182\/asheducation-2004.1.457","article-title":"Transfusion medicine: Joint ASH and AABB educational session","volume":"1","author":"Goodnough","year":"2004","journal-title":"Hematology"},{"issue":"6851","key":"10.1002\/14651858.CD007578.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1136\/bmj.305.6851.478-b","article-title":"Victims of Creutzfeldt-Jakob disease","volume":"305","author":"Grant","year":"1992","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0120|cit120","first-page":"S1","article-title":"Calming the madness: America's panic over mad cow disease has been fueled by misinformation, inexact science and alarmist media reports","volume":"5 March","author":"Green","year":"2001","journal-title":"Los Angeles Times -- Southern California Edition (Front Page)"},{"issue":"5","key":"10.1002\/14651858.CD007578.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/eurpub\/cki016","article-title":"Public understanding of food risks in four European countries: A qualitative study","volume":"15","author":"Green","year":"2005","journal-title":"European Journal of Public Health"},{"issue":"7037","key":"10.1002\/14651858.CD007578.pub2-BIB0122|cit122","first-page":"1038","article-title":"Creutzfeldt-Jakob disease and bovine spongiform encephalopathy - doctors and scientists must be able to communicate degree of risk ... but members of the public make up their own minds about risks","volume":"312","author":"Gunasekera","year":"1996","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jhin.2004.01.009","article-title":"Dental treatment of a patient in the new 'at-risk' category for CJD","volume":"57","author":"Hamilton","year":"2004","journal-title":"Journal of Hospital Infection"},{"issue":"4","key":"10.1002\/14651858.CD007578.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/00003226-200405000-00019","article-title":"Creutzfeldt-Jakob disease following corneal transplantation","volume":"23","author":"Hammersmith","year":"2004","journal-title":"Cornea"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00003226-200501000-00025","article-title":"Informed consent for Creutzfeldt-Jakob disease after corneal transplantation [reply]","volume":"24","author":"Hammersmith","year":"2005","journal-title":"Cornea"},{"issue":"52","key":"10.1002\/14651858.CD007578.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7748\/ns.17.52.18.s29","article-title":"The CJD mystery","volume":"17","author":"Hampshire","year":"2003","journal-title":"Nursing Standard"},{"issue":"1-3","key":"10.1002\/14651858.CD007578.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0048-9697(02)00539-9","article-title":"Knowledge, attitude, and behavior of students regarding 'mad cow disease'","volume":"312","author":"Harakeh","year":"2003","journal-title":"Science of the Total Environment"},{"issue":"4","key":"10.1002\/14651858.CD007578.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0003-4878(98)00035-0","article-title":"Facts, fallacies and fears: The public and the health professionals at odds","volume":"42","author":"Harrington","year":"1998","journal-title":"Annals of Occupational Hygiene"},{"issue":"7037","key":"10.1002\/14651858.CD007578.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/bmj.312.7037.1037c","article-title":"Creutzfeldt-Jakob disease and bovine spongiform encephalopathy - doctors and scientists must be able to communicate degree of risk","volume":"312","author":"Harrison","year":"1996","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD007578.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tmrv.2004.03.001","article-title":"Informed consent for blood transfusion: Should the possibility of prion risk be included?","volume":"18","author":"Hart","year":"2004","journal-title":"Transfusion Medicine Reviews"},{"issue":"39","key":"10.1002\/14651858.CD007578.pub2-BIB0131|cit131","first-page":"3","article-title":"vCJD alert is 'upsetting' for all involved","volume":"100","author":"Hartley","year":"2004","journal-title":"Nursing Times"},{"issue":"4","key":"10.1002\/14651858.CD007578.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/03033910.1996.10558117","article-title":"Communication failure on environmental and health issues","volume":"17","author":"Harvey","year":"1996","journal-title":"The Irish Journal of Psychology"},{"issue":"6903","key":"10.1002\/14651858.CD007578.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/bmj.307.6903.517","article-title":"Creutzfeldt-Jakob disease after pituitary gonadotrophins","volume":"307","author":"Healy","year":"1993","journal-title":"BMJ"},{"issue":"5510","key":"10.1002\/14651858.CD007578.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1126\/science.291.5510.1859","article-title":"vCJD: broad U.S. response required","volume":"291","author":"Healy","year":"2001","journal-title":"Science"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1423-0410.2006.00833.x","article-title":"Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Epidemiological Review study","volume":"91","author":"Hewitt","year":"2006","journal-title":"Vox Sanguinis"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1258\/147775006778246478","article-title":"vCJD donor notification exercise: 2005","volume":"1","author":"Hewitt","year":"2006","journal-title":"Clinical Ethics"},{"issue":"7","key":"10.1002\/14651858.CD007578.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1365-2044.2004.03846.x","article-title":"Percutaneous tracheostomy and Creutzfeldt-Jakob Disease","volume":"59","author":"Higgins","year":"2004","journal-title":"Anaesthesia"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/1475-5661.00014","article-title":"Indeterminacy in-decisions - science, policy and politics in the BSE (Bovine Spongiform Encephalopathy) crisis","volume":"26","author":"Hinchliffe","year":"2001","journal-title":"Transactions of the Institute of British Geographers"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1086\/JCE200112209","article-title":"Comment: limiting toxic information [comment]","volume":"12","author":"Howe","year":"2001","journal-title":"Journal of Clinical Ethics"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0140|cit140","unstructured":"HPA Centre for Infections CJD Section Report of seminar on ethical and social aspects of testing for vCJD www.hpa.org.uk\/infections\/topics_az\/cjd\/ethicalsocialtesting.pdf (accessed 12 March 2008) October 2005"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0141|cit141","unstructured":"Health Protection Agency vCJD and plasma products - Clinical Information www.hpa.org.uk\/infections\/topics_az\/cjd\/vCJDplasma-Clinical.pdf (accessed 11 January 2008) January 2007"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0142|cit142","unstructured":"Health Protection Agency and Health Protection Scotland Creutzfeldt-Jakob disease (CJD) and surgery: Clinical Information www.hpa.org.uk\/infections\/topics_az\/cjd\/CJDsurgexpClinical.pdf (accessed 11 January 2008) October 2006"},{"issue":"3","key":"10.1002\/14651858.CD007578.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/096973309600300309","article-title":"Some ethical ground rules for BSE and other public health threats [comment]","volume":"3","author":"Hunt","year":"1996","journal-title":"Nursing Ethics"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/978-3-7091-6892-9_16","article-title":"Human prion diseases","volume":"Suppl 47","author":"Ironside","year":"1996","journal-title":"Journal of Neural Transmission"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007578.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2516.2006.01195.x","article-title":"Variant Creutzfeldt-Jakob disease: risk of transmission by blood transfusion and blood therapies","volume":"12","author":"Ironside","year":"2006","journal-title":"Haemophilia"},{"issue":"1-3","key":"10.1002\/14651858.CD007578.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0304-3894(00)00228-4","article-title":"Policy understanding of science, public trust and the BSE-CJD crisis","volume":"78","author":"Jacob","year":"2000","journal-title":"Journal of Hazardous Materials"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0147|cit147","first-page":"2","article-title":"Mad cow disease: management by crisis","volume":"31","author":"Jacobson","year":"2004","journal-title":"Nutrition Action Health Letter"},{"issue":"13","key":"10.1002\/14651858.CD007578.pub2-BIB0148|cit148","first-page":"117","article-title":"First case of variant Creutzfeldt-Jakob disease in Canada [erratum appears in Can Commun Dis Rep. 2003 Aug 1;29(15):136]","volume":"29","author":"Jansen","year":"2003","journal-title":"Canada Communicable Disease Report"},{"issue":"4","key":"10.1002\/14651858.CD007578.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-2044.2003.03095_4.x","article-title":"Problems with disposable laryngoscope blades [multiple letters]","volume":"58","author":"Jefferson","year":"2003","journal-title":"Anaesthesia"},{"issue":"11","key":"10.1002\/14651858.CD007578.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/175045890601601105","article-title":"Decontamination and CJD: the latest guidance","volume":"16","author":"Jeffries","year":"2006","journal-title":"Journal of Perioperative Practice"},{"issue":"23","key":"10.1002\/14651858.CD007578.pub2-BIB0151|cit151","first-page":"ii","article-title":"Imported falciparum malaria in Europe: 2007 data from TropNetEurop","volume":"13","author":"Jelinek","year":"2008","journal-title":"Bulletin Europeen sur les Maladies Transmissibles [European Communicable Disease Bulletin]"},{"issue":"27","key":"10.1002\/14651858.CD007578.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJM199812313392707","article-title":"Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies","volume":"339","author":"Johnson","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007578.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11910-007-0027-1","article-title":"Good and bad news about transmissible spongiform encephalopathies (prion diseases)","volume":"7","author":"Johnson","year":"2007","journal-title":"Current Neurology & Neuroscience Reports"},{"issue":"6","key":"10.1002\/14651858.CD007578.pub2-BIB0154|cit154","first-page":"332","article-title":"Creutzfeldt-Jakob disease and infection control","volume":"12","author":"Johnston","year":"2001","journal-title":"Canadian Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0155|cit155","first-page":"71","article-title":"Brief communication CME Bulletin","volume":"5","author":"Kapoor","year":"2001","journal-title":"Otorhinolaryngology Head and Neck Surgery"},{"issue":"7","key":"10.1002\/14651858.CD007578.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/humrep\/13.7.1777","article-title":"Creutzfeldt-Jakob disease (CJD) and assisted reproductive technology (ART). Quantification of risks as part of informed consent","volume":"13","author":"Kemmann","year":"1998","journal-title":"Human Reproduction"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/13698570802159907","article-title":"The shifting sands of uncertainty: Risk construction and BSE\/vCJD","volume":"10","author":"Kewell","year":"2008","journal-title":"Health, Risk and Society"},{"issue":"7580","key":"10.1002\/14651858.CD007578.pub2-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1136\/bmj.39051.730463.47","article-title":"Minerva","volume":"333","author":"Khashia","year":"2006","journal-title":"BMJ"},{"issue":"7","key":"10.1002\/14651858.CD007578.pub2-BIB0159|cit159","first-page":"771","article-title":"Notifying patients exposed to blood products associated with Creutzfeldt-Jakob disease: theoretical risk for real people","volume":"159","author":"King","year":"1998","journal-title":"CMAJ"},{"issue":"12","key":"10.1002\/14651858.CD007578.pub2-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1365-2044.2001.02369.x","article-title":"Collaborative infection control policies for anaesthetic equipment are needed [multiple letters]","volume":"56","author":"King","year":"2001","journal-title":"Anaesthesia"},{"issue":"9613","key":"10.1002\/14651858.CD007578.pub2-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(08)60286-X","article-title":"French doctors on trial for manslaughter","volume":"371","author":"King","year":"2008","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10730-007-9040-7","article-title":"An innovative, inclusive process for meso-level health policy development","volume":"19","author":"Kirby","year":"2007","journal-title":"HEC Forum"},{"issue":"3","key":"10.1002\/14651858.CD007578.pub2-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1054\/bjps.2002.3823","article-title":"Department of health withdraws variant CJD transmission recommendations for single-use instruments","volume":"55","author":"Kirkpatrick","year":"2002","journal-title":"British Journal of Plastic Surgery"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0164|cit164","unstructured":"Kirkup B Department of Health Incident arising in October 2002 from a patient with Creutzfeldt-Jakob disease in Middlesbrough. Report of incident review www.dh.gov.uk\/en\/Publicationsandstatistics\/Publications\/PublicationsPolicyAndGuidance\/DH_4008283 (accessed 11 January 2008)"},{"issue":"Suppl","key":"10.1002\/14651858.CD007578.pub2-BIB0165|cit165","first-page":"72","article-title":"Genetic studies in relation to kuru. 3. Distribution of the inherited serum group-specific protein (Ge) phenotypes in New Guineans: an association of kuru and the Gc Ab phenotype","volume":"24","author":"Kitchin","year":"1972","journal-title":"American Journal of Human Genetics"},{"issue":"7269","key":"10.1002\/14651858.CD007578.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/bmj.321.7269.1091","article-title":"The politics of risk: the case of BSE. If we want less paternalism we must first educate ourselves","volume":"321","author":"Klein","year":"2000","journal-title":"BMJ"},{"issue":"7468","key":"10.1002\/14651858.CD007578.pub2-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/bmj.329.7468.702-c","article-title":"Patients informed of increased risk of vCJD contact","volume":"329","author":"Kmietowicz","year":"2004","journal-title":"BMJ"},{"issue":"1-3","key":"10.1002\/14651858.CD007578.pub2-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0378-4274(01)00287-9","article-title":"Science, uncertainty and policy: Food for thought","volume":"120","author":"Krebs","year":"2001","journal-title":"Toxicology Letters"},{"issue":"12","key":"10.1002\/14651858.CD007578.pub2-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/sj.embor.7401132","article-title":"Public health and civil liberties. Introduction to the talking point on public health versus civil liberties","volume":"8","author":"Kurth","year":"2007","journal-title":"EMBO Reports"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0170|cit170","first-page":"46","article-title":"Internet. Serving clients with progressive dementias","volume":"41","author":"Kuster","year":"1999","journal-title":"ASHA"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0171|cit171","first-page":"5","article-title":"It's not a small world after all","volume":"45","author":"Landals","year":"2004","journal-title":"Canadian Veterinary Journal"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2307\/3343296","article-title":"The mad cow problem in the uk - risk perceptions, risk management, and health policy development","volume":"19","author":"Lanska","year":"1998","journal-title":"Journal of Public Health Policy"},{"issue":"7","key":"10.1002\/14651858.CD007578.pub2-BIB0173|cit173","first-page":"789","article-title":"The quandary of Creutzfeldt-Jakob disease [comment]","volume":"159","author":"Larke","year":"1998","journal-title":"CMAJ"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0174|cit174","unstructured":"Lee P Report of the review of events around suspected Creutzfeldt-Jakob Disease (CJD) in Nova Scotia www.gov.ns.ca\/health\/downloads\/final_CJD_Report.pdf (accessed 18 March 2008)"},{"issue":"17","key":"10.1002\/14651858.CD007578.pub2-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1080\/15287390903084611","article-title":"Internation case studies of psychosocial ripple effects of Bovine Spongiform Encephalopathy (BSE) in European countries","volume":"72","author":"Lemyre","year":"2009","journal-title":"Journal of Toxicology and Environmental Health, Part A"},{"issue":"8917","key":"10.1002\/14651858.CD007578.pub2-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0140-6736(94)93014-7","article-title":"CJD surveillance in Europe","volume":"344","author":"Lewis","year":"1994","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD007578.pub2-BIB0177|cit177","first-page":"I","article-title":"Preface","volume":"43","author":"Liberski","year":"2005","journal-title":"Folia Neuropathologica"},{"issue":"9407","key":"10.1002\/14651858.CD007578.pub2-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(04)15486-X","article-title":"Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion [see comment]","volume":"363","author":"Llewelyn","year":"2004","journal-title":"Lancet"},{"issue":"12","key":"10.1002\/14651858.CD007578.pub2-BIB0179|cit179","first-page":"14","article-title":"Prion diseases: Creutzfeldt-Jakob disease, bovine spongiform encephalopathy (mad cow disease), and variant Creutzfeldt-Jakob disease","volume":"21","author":"Lovasik","year":"2004","journal-title":"AACN News"},{"issue":"6","key":"10.1002\/14651858.CD007578.pub2-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/10731190600974038","article-title":"Genomics and blood substitutes for 21st century Europe (\"EuroBloodSubstitutes\")","volume":"34","author":"Lowe","year":"2006","journal-title":"Artificial Cells, Blood Substitutes, & Immobilization Biotechnology"},{"issue":"4","key":"10.1002\/14651858.CD007578.pub2-BIB0181|cit181","first-page":"377","article-title":"[Comparison of three scales to assess health risk perception]","volume":"49","author":"Lukasiewicz","year":"2001","journal-title":"Revue d Epidemiologie et de Sante Publique"},{"issue":"3","key":"10.1002\/14651858.CD007578.pub2-BIB0182|cit182","first-page":"394","article-title":"\"Mad cow disease\": What you - and your patients need to know now","volume":"44","author":"Lurie","year":"2004","journal-title":"Consultant"},{"issue":"6848","key":"10.1002\/14651858.CD007578.pub2-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/bmj.305.6848.312-c","article-title":"Monitoring Creutzfeldt-Jakob disease [comment]","volume":"305","author":"Lyons","year":"1992","journal-title":"BMJ"},{"issue":"7","key":"10.1002\/14651858.CD007578.pub2-BIB0184|cit184","first-page":"212","article-title":"International disease surveillance [comment]","volume":"154","author":"Lysons","year":"2004","journal-title":"Veterinary Record"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1467-3010.2001.00102.x","article-title":"Finding a recipe to remove uncertainty","volume":"26","author":"MacEvilly","year":"2001","journal-title":"Nutrition Bulletin"},{"issue":"7","key":"10.1002\/14651858.CD007578.pub2-BIB0186|cit186","first-page":"178","article-title":"Hospital acquired infection - The current situation","volume":"7","author":"Mannion","year":"2000","journal-title":"Hospital Pharmacist"},{"issue":"7","key":"10.1002\/14651858.CD007578.pub2-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2105\/AJPH.86.7.921","article-title":"From alcohol and breast cancer to beef and BSE--improving our communication of risk","volume":"86","author":"Marmot","year":"1996","journal-title":"American Journal of Public Health"},{"issue":"5","key":"10.1002\/14651858.CD007578.pub2-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.tracli.2006.11.003","article-title":"Transfusion risk analysis with regard to vCJD in France","volume":"13","author":"Martin","year":"2006","journal-title":"Transfusion Clinique et Biologique"},{"issue":"3","key":"10.1002\/14651858.CD007578.pub2-BIB0189|cit189","first-page":"74","article-title":"[Prion diseases]","volume":"26","author":"Martinez","year":"2003","journal-title":"Revista de Enfermeria"},{"issue":"4","key":"10.1002\/14651858.CD007578.pub2-BIB0190|cit190","first-page":"160","article-title":"The emerging European epidemic of variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: Lessons for Australia","volume":"174","author":"Masters","year":"2001","journal-title":"MJA"},{"issue":"9008","key":"10.1002\/14651858.CD007578.pub2-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0140-6736(96)90293-7","article-title":"Usa launches variant CJD surveillance","volume":"347","author":"McCarthy","year":"1996","journal-title":"Lancet"},{"issue":"9071","key":"10.1002\/14651858.CD007578.pub2-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0140-6736(05)61825-9","article-title":"Warning bell sounded about diagnosis of nvCJD","volume":"350","author":"McCarthy","year":"1997","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"251","DOI":"10.20506\/rst.22.1.1396","article-title":"Risk communication of the transmissible spongiform encephalopathies","volume":"22","author":"McCrea","year":"2003","journal-title":"Revue Scientifique et Technique"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"141","DOI":"10.20506\/rst.24.1.1554","article-title":"Risk communication related to animal products derived from biotechnology","volume":"24","author":"McCrea","year":"2005","journal-title":"Revue Scientifique et Technique"},{"issue":"5","key":"10.1002\/14651858.CD007578.pub2-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1537-2995.2004.03310.x","article-title":"Consensus conference on vCJD screening of blood donors: report of the panel [see comment]","volume":"44","author":"McCullough","year":"2004","journal-title":"Transfusion"},{"issue":"Suppl 115","key":"10.1002\/14651858.CD007578.pub2-BIB0196|cit196","first-page":"55","article-title":"New and emerging pathogens","author":"McDade","year":"2000","journal-title":"International Journal of Clinical Practice"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0197|cit197","first-page":"23","article-title":"Infectious diseases","volume":"176","author":"McDonald","year":"2002","journal-title":"MJA"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0198|cit198","first-page":"75","article-title":"Mad cow disease","volume":"4","author":"McIntosh","year":"2002","journal-title":"Journal of Continuing Education Topics & Issues"},{"issue":"22","key":"10.1002\/14651858.CD007578.pub2-BIB0199|cit199","first-page":"15","article-title":"Continuing education - 271. Mad cow and new-variant Creutzfeldt-Jakob diseases","volume":"10","author":"McMahon","year":"2001","journal-title":"Nursing Spectrum - Philadelphia Tri-State Edition"},{"issue":"8","key":"10.1002\/14651858.CD007578.pub2-BIB0200|cit200","first-page":"71","article-title":"Continuing education: earning CEUs. Mad cow & new-variant Creutzfeldt-Jakob diseases","volume":"11","author":"McMahon","year":"2004","journal-title":"Healthcare Traveler"},{"issue":"8993","key":"10.1002\/14651858.CD007578.pub2-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(96)91601-3","article-title":"Creutzfeldt-Jakob disease [comment]","volume":"347","author":"McPherson","year":"1996","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD007578.pub2-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jhin.2005.02.003","article-title":"Questionnaire to reduce the risk of iatrogenic prion disease transmission","volume":"60","author":"Mead","year":"2005","journal-title":"Journal of Hospital Infection"},{"issue":"3","key":"10.1002\/14651858.CD007578.pub2-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1006\/biol.1996.0035","article-title":"Creutzfeldt-Jakob disease: current U.S. policy to further reduce the possible risk of transmission by transfusion","volume":"24","author":"Menache","year":"1996","journal-title":"Biologicals"},{"issue":"10","key":"10.1002\/14651858.CD007578.pub2-BIB0204|cit204","first-page":"14","article-title":"Prion-transmissible diseases... \"The risk of transfusion-transmitted prion infection\"","volume":"32","author":"Milner","year":"2000","journal-title":"Medical Laboratory Observer"},{"issue":"5","key":"10.1002\/14651858.CD007578.pub2-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/01376517-199810000-00005","article-title":"The spongiform encephalopathies: prion diseases","volume":"30","author":"Mocsny","year":"1998","journal-title":"Journal of Neuroscience Nursing"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0206|cit206","first-page":"E060126.4","article-title":"Variant Creutzfeldt-Jakob disease in the United Kingdom and elsewhere: situation at the end of 2005 [erratum]","volume":"11","author":"Molesworth","year":"2006","journal-title":"Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles [European Communicable Disease Bulletin]"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0207|cit207","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0887-7963(98)80033-3","article-title":"Surveillance of blood transfusion safety - contribution of the hemovigilance strategy in France","volume":"12","author":"Morel","year":"1998","journal-title":"Transfusion Medicine Reviews"},{"issue":"4","key":"10.1002\/14651858.CD007578.pub2-BIB0208|cit208","first-page":"179","article-title":"Networks of institutions as a part of global vigilance system on communicable diseases","volume":"40","author":"Morita","year":"1998","journal-title":"Tropical Medicine"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0209|cit209","first-page":"17","article-title":"Time well spent: counselling people with CJD and their families","volume":"7","author":"Morris","year":"2007","journal-title":"Healthcare Counselling & Psychotherapy Journal"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1365-2524.2002.00346.x","article-title":"Variant Creutzfeldt-Jakob disease: costs borne by families","volume":"10","author":"Myles","year":"2002","journal-title":"Health and Social Care in the Community"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0211|cit211","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.ico.0000151725.01884.ea","article-title":"Informed consent for Creutzfeldt-Jakob disease after corneal transplantation [multiple letters]","volume":"24","author":"Najjar","year":"2005","journal-title":"Cornea"},{"issue":"5","key":"10.1002\/14651858.CD007578.pub2-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/01376517-198810000-00008","article-title":"Creutzfeldt-Jakob disease","volume":"20","author":"Neatherlin","year":"1988","journal-title":"Journal of Neuroscience Nursing"},{"issue":"10","key":"10.1002\/14651858.CD007578.pub2-BIB0213|cit213","first-page":"603","article-title":"Neurosurgery and iatrogenic transmission of Creutzfeldt-Jakob disease","volume":"164","author":"Newcombe","year":"1996","journal-title":"MJA"},{"issue":"5655","key":"10.1002\/14651858.CD007578.pub2-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.303.5655.156","article-title":"First U.S. case of Mad Cow sharpens debate over testing","volume":"303","author":"Normile","year":"2004","journal-title":"Science"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0215|cit215","unstructured":"New South Wales Government Department of Health Response protocol for NSW Public Health Units www.health.nsw.gov.au\/factsheets\/guideline\/cjd.html (accessed 18 March 2008)"},{"issue":"4","key":"10.1002\/14651858.CD007578.pub2-BIB0216|cit216","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/pubmed\/23.4.351","article-title":"Quarterly communicable disease review April to June 2001: From the PHLS communicable disease surveillance centre","volume":"23","author":"O'Brien","year":"2001","journal-title":"Journal of Public Health Medicine"},{"issue":"6","key":"10.1002\/14651858.CD007578.pub2-BIB0217|cit217","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00464-004-9205-2","article-title":"Variant Creutzfeldt-Jakob disease, a cause for concern: Review of the evidence for risk of transmission through abdominal lymphoreticular tissue surgery","volume":"19","author":"Olsen","year":"2005","journal-title":"Surgical Endoscopy"},{"issue":"8984","key":"10.1002\/14651858.CD007578.pub2-BIB0218|cit218","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S0140-6736(95)92925-8","article-title":"Pooled plasma derivatives and Creutzfeldt-Jakob disease","volume":"346","author":"Operskalshi","year":"1995","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1053\/jinf.2000.0703","article-title":"Variant Creutzfeldt Jakob disease","volume":"41","author":"Painter","year":"2000","journal-title":"Journal of Infection"},{"issue":"6","key":"10.1002\/14651858.CD007578.pub2-BIB0220|cit220","first-page":"42","article-title":"Creutzfeld-Jakob disease: the Grace General Hospital experience","volume":"5","author":"Pauls","year":"1996","journal-title":"Leadership in Health Services"},{"issue":"4","key":"10.1002\/14651858.CD007578.pub2-BIB0221|cit221","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1024\/\/0044-3514.32.4.213","article-title":"BSE: Social psychological aspects of a controversial risk","volume":"32","author":"Pfister","year":"2001","journal-title":"Zeitschrift fur Sozialpsychologie"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007578.pub2-BIB0222|cit222","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2516.2006.01193.x","article-title":"Implications of emerging pathogens in the management of haemophilia","volume":"12","author":"Pipe","year":"2006","journal-title":"Haemophilia"},{"issue":"4","key":"10.1002\/14651858.CD007578.pub2-BIB0223|cit223","first-page":"336","article-title":"Infectious diseases and governance of global risks through public communication and participation","volume":"43","author":"Pitrelli","year":"2007","journal-title":"Annali Dell'Istituto Superiore di Sanita"},{"issue":"9253","key":"10.1002\/14651858.CD007578.pub2-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)71535-X","article-title":"BSE report","volume":"357","author":"Podger","year":"2001","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0225|cit225","unstructured":"Populus for the Health Protection Agency and the Department of Health UK Populus study: Opinion-former attitudes towards the possible introduction of a vCJD test for blood donations www.dh.gov.uk\/en\/Publicationsandstatistics\/Publications\/PublicationsPolicyAndGuidance\/DH_073487 (accessed 17 December 2007)"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0226|cit226","first-page":"1","article-title":"Variant Creutzfeldt-Jakob disease and the potential for its accidental transmission following surgery with contaminated instruments: The risk of transmission in Australia","volume":"41","author":"Ramasamy","year":"2003","journal-title":"Folia Neuropathologica"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0227|cit227","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.tmrv.2003.10.005","article-title":"Managing recalls and withdrawals of blood components","volume":"18","author":"Ramsey","year":"2004","journal-title":"Transfusion Medicine Reviews"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0228|cit228","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/108107398127382","article-title":"Ethical research and practice of how we communicate health and risk","volume":"3","author":"Ratzan","year":"1998","journal-title":"Journal of Health Communication"},{"issue":"3","key":"10.1002\/14651858.CD007578.pub2-BIB0229|cit229","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/108107398127300","article-title":"United Nations address","volume":"3","author":"Ratzan","year":"1998","journal-title":"Journal of Health Communication"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0230|cit230","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1423-0410.2003.00343.x","article-title":"Future counselling of donors and recipients of blood products concerning prion-related diseases","volume":"85","author":"Reesink","year":"2003","journal-title":"Vox Sanguinis"},{"issue":"12","key":"10.1002\/14651858.CD007578.pub2-BIB0231|cit231","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/jama.1996.03540120016009","article-title":"Surveillance for Creutzfeldt-Jakob disease - United States (reprinted from MMWR, vol 45, pg 665-668, 1996)","volume":"276","author":"Reingold","year":"1996","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD007578.pub2-BIB0232|cit232","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/01.NJH.0000319180.71035.26","article-title":"Nursing care of the person with sporadic Creutzfeldt-Jakob disease","volume":"10","author":"Rentz","year":"2008","journal-title":"Journal of Hospice & Palliative Nursing"},{"issue":"10","key":"10.1002\/14651858.CD007578.pub2-BIB0233|cit233","first-page":"1367","article-title":"Is Creutzfeldt-Jakob disease transmitted in blood? Is the absence of evidence of risk evidence of the absence of risk? [see comment]","volume":"157","author":"Ricketts","year":"1997","journal-title":"CMAJ"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0234|cit234","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000060379","article-title":"The prion theory: Background and basic information","volume":"7","author":"Riesner","year":"2001","journal-title":"Prions : A Challenge For Science, Medicine And Public Health System"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0235|cit235","first-page":"9","article-title":"What would you do? Results and discussion","volume":"14","author":"Roberts","year":"1999","journal-title":"Canadian Journal of Infection Control"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0236|cit236","doi-asserted-by":"crossref","first-page":"265","DOI":"10.33321\/cdi.2002.26.24","article-title":"Evaluation of the Australian CJD surveillance system [erratum appears in Commun Dis Intell 2002;26(3):374]","volume":"26","author":"Robotin","year":"2002","journal-title":"Communicable Diseases Intelligence"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0237|cit237","first-page":"84","article-title":"Variant Creutzfeldt-Jakob disease and prions in the blood supply","volume":"2","author":"Rohwer","year":"2004","journal-title":"Clinical Advances in Hematology & Oncology"},{"issue":"20","key":"10.1002\/14651858.CD007578.pub2-BIB0238|cit238","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM200105173442012","article-title":"Controlling new prion diseases","volume":"344","author":"Roos","year":"2001","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD007578.pub2-BIB0239|cit239","first-page":"10","article-title":"Creutzfeldt-Jakob disease","volume":"34","author":"Ross","year":"2002","journal-title":"Surgical Technologist"},{"issue":"2408","key":"10.1002\/14651858.CD007578.pub2-BIB0240|cit240","first-page":"1853","article-title":"Creutzfeldt-Jakob disease: Risks of nosocomial transmission in Switzerland, in 2002","volume":"60","author":"Ruef","year":"2002","journal-title":"Medecine et Hygiene"},{"issue":"5","key":"10.1002\/14651858.CD007578.pub2-BIB0241|cit241","first-page":"408","article-title":"[Evaluation of risks related to blood transfusions in industrialized countries]","volume":"42","author":"Salamon","year":"1994","journal-title":"Revue d Epidemiologie et de Sante Publique"},{"issue":"9","key":"10.1002\/14651858.CD007578.pub2-BIB0242|cit242","doi-asserted-by":"crossref","first-page":"265","DOI":"10.33321\/cdi.2000.24.44","article-title":"Creutzfeldt-Jakob disease surveillance- Australia at the crossroads?","volume":"24","author":"Sanders","year":"2000","journal-title":"Communicable Diseases Intelligence"},{"issue":"6","key":"10.1002\/14651858.CD007578.pub2-BIB0243|cit243","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/01.moh.0000245693.39709.fa","article-title":"Variant Creutzfeldt-Jacob disease - the availability of a screening test will be the beginning, not the end, of difficult transfusion-related issues","volume":"13","author":"Sandler","year":"2006","journal-title":"Current Opinion in Hematology"},{"issue":"9","key":"10.1002\/14651858.CD007578.pub2-BIB0244|cit244","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/ncpneuro0606","article-title":"The Huntington's disease-like syndromes: What to consider in patients with a negative Huntington's disease gene test","volume":"3","author":"Schneider","year":"2007","journal-title":"Nature Clinical Practice Neurology"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0245|cit245","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1017\/S019594170000045X","article-title":"CJD update","volume":"19","author":"Sehulster","year":"1998","journal-title":"Infection Control & Hospital Epidemiology"},{"issue":"3-4","key":"10.1002\/14651858.CD007578.pub2-BIB0246|cit246","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000087828","article-title":"Variant Creutzfeldt-Jakob disease","volume":"32","author":"Seitz","year":"2005","journal-title":"Transfusion Medicine and Hemotherapy"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0247|cit247","unstructured":"Parliament of Australia Senate Report on the CJD Settlement Offer http:\/\/202.14.81.34\/senate\/committee\/clac_ctte\/completed_inquiries\/1996-99\/cjd\/report\/index.htm (accessed 4 April 2008) October 1997"},{"issue":"8","key":"10.1002\/14651858.CD007578.pub2-BIB0248|cit248","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/599004","article-title":"Ethical analysis of communicating the risk of iatrogenic Creutzfeldt-Jakob Disease","volume":"30","author":"Shalowitz","year":"2009","journal-title":"Infection Control and Hospital Epidemiology"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0249|cit249","unstructured":"Shamrock Marketing Interim Report for CJD Consultation Process prepared for the Department of Health www.dh.gov.uk\/en\/Publichealth\/Communicablediseases\/CJD\/CJDgeneralinformation\/DH_4031023 (accessed 18 March 2008)"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0250|cit250","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00152193-200502000-00052","article-title":"Mad cow disease and vCJD: understanding the risks","volume":"35","author":"Sheff","year":"2005","journal-title":"Nursing"},{"issue":"3","key":"10.1002\/14651858.CD007578.pub2-BIB0251|cit251","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1023\/A:1026585019832","article-title":"\"On a supposed right to lie [to the public] from benevolent motives\": communicating health risks to the public [see comment]","volume":"3","author":"Shickle","year":"2000","journal-title":"Medicine, Health Care & Philosophy"},{"issue":"7","key":"10.1002\/14651858.CD007578.pub2-BIB0252|cit252","first-page":"829","article-title":"Blood recipients and CJD: to notify or not to notify, that is the question [comment]","volume":"159","author":"Sibbald","year":"1998","journal-title":"CMAJ"},{"issue":"3","key":"10.1002\/14651858.CD007578.pub2-BIB0253|cit253","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S1246-7820(00)80002-6","article-title":"Blood transfusion and principle of precaution","volume":"7","author":"Sicard","year":"2000","journal-title":"Transfusion Clinique et Biologique"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0254|cit254","first-page":"16","article-title":"BSE and scrapie - Safety measures for medicinal products in Germany","volume":"40","author":"Sickmuller","year":"1997","journal-title":"Drugs Made in Germany"},{"issue":"10 Suppl 2","key":"10.1002\/14651858.CD007578.pub2-BIB0255|cit255","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.ajic.2007.10.007","article-title":"2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings","volume":"35","author":"Siegel","year":"2007","journal-title":"American Journal of Infection Control"},{"issue":"2486","key":"10.1002\/14651858.CD007578.pub2-BIB0256|cit256","first-page":"1297","article-title":"What are the risks of blood transfusion in 2003? Part 2: Emergent risks, risks associated with transfusion therapy, principles of the hemovigilance system","volume":"62","author":"Siegenthaler","year":"2004","journal-title":"Medecine et Hygiene"},{"issue":"7065","key":"10.1002\/14651858.CD007578.pub2-BIB0257|cit257","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1136\/bmj.313.7065.1146a","article-title":"Bovine spongiform encephalopathy - study shows need for better communication between government and doctors","volume":"313","author":"Simpson","year":"1996","journal-title":"BMJ"},{"issue":"1044","key":"10.1002\/14651858.CD007578.pub2-BIB0258|cit258","first-page":"177","article-title":"Creutzfeldt-Jakob disease","volume":"110","author":"Skegg","year":"1997","journal-title":"New Zealand Medical Journal"},{"issue":"11-12","key":"10.1002\/14651858.CD007578.pub2-BIB0259|cit259","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1108\/03090569910292294","article-title":"How now, mad-cow? Consumer confidence and source credibility during the 1996 BSE scare","volume":"33","author":"Smith","year":"1999","journal-title":"European Journal of Marketing"},{"issue":"6","key":"10.1002\/14651858.CD007578.pub2-BIB0260|cit260","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.bdj.4810542","article-title":"Prion diseases and dental treatment: principles and practice of patients with\/suspected or at-risk of CJD: Case reports","volume":"195","author":"Smith","year":"2003","journal-title":"British Dental Journal"},{"issue":"5","key":"10.1002\/14651858.CD007578.pub2-BIB0261|cit261","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/ije\/dyg305","article-title":"Uncertainty and significance","volume":"32","author":"Smith","year":"2003","journal-title":"International Journal of Epidemiology"},{"issue":"20","key":"10.1002\/14651858.CD007578.pub2-BIB0262|cit262","first-page":"52","article-title":"Creutzfeldt-Jakob disease: diagnosis and nursing care issues","volume":"101","author":"Smith-Bathgate","year":"2005","journal-title":"Nursing Times"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0263|cit263","first-page":"34","article-title":"Recent BSE concerns and the relevance of clearance studies","volume":"Spring","author":"Sofer","year":"2004","journal-title":"European Biopharmaceutical Review"},{"issue":"7","key":"10.1002\/14651858.CD007578.pub2-BIB0264|cit264","first-page":"E050721.5","article-title":"UK blood donors identified as at increased risk of vCJD are to be notified of their status","volume":"10","author":"Soldan","year":"2005","journal-title":"Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles [European Communicable Disease Bulletin]"},{"issue":"3","key":"10.1002\/14651858.CD007578.pub2-BIB0265|cit265","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1053\/jhin.2002.1244","article-title":"Sterilization issues in vCJD - Towards a consensus","volume":"51","author":"Spencer","year":"2002","journal-title":"Journal of Hospital Infection"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0266|cit266","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.ico.0000151726.09507.f9","article-title":"Informed consent for Creutzfeldt-Jakob disease after corneal transplantation [comment]","volume":"24","author":"Srinivasan","year":"2005","journal-title":"Cornea"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0267|cit267","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.transci.2004.07.006","article-title":"6 years of shot reporting - its influence on UK blood safety","volume":"31","author":"Stainsby","year":"2004","journal-title":"Transfusion & Apheresis Science"},{"issue":"5","key":"10.1002\/14651858.CD007578.pub2-BIB0268|cit268","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0196-6553(94)90019-1","article-title":"Creutzfeld-Jakob disease: Recommendations for infection control","volume":"22","author":"Steelman","year":"1994","journal-title":"American Journal of Infection Control"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0269|cit269","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1086\/JCE200112207","article-title":"Informing a recipient of blood from a donor who developed Creutzfeld-Jakob disease: The characteristics of information that warrant its disclosure","volume":"12","author":"Steinberg","year":"2001","journal-title":"Journal of Clinical Ethics"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0270|cit270","unstructured":"Steinberg D What information should be disclosed to patients? Lahey Clinic Medical Ethics (\/\/www.lahey.org\/NewsPubs\/Publications\/Ethics\/JournalFall2002\/Journal_Fall2002_Feature.asp) (accessed 28 May 2007) 2002"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD007578.pub2-BIB0271|cit271","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0195-6701(07)60007-3","article-title":"Halting the spread of human prion disease - exceptional measures for an exceptional problem","volume":"65","author":"Stephenson","year":"2007","journal-title":"Journal of Hospital Infection"},{"issue":"10","key":"10.1002\/14651858.CD007578.pub2-BIB0272|cit272","first-page":"1405","article-title":"Creutzfeldt-Jakob disease: the Canadian situation [see comment]","volume":"157","author":"Stratton","year":"1997","journal-title":"CMAJ"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0273|cit273","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3201\/eid0301.970108","article-title":"The epidemiology of CJD in Canada: a review of mortality data","volume":"3","author":"Stratton","year":"1997","journal-title":"Emerging Infectious Diseases"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0274|cit274","first-page":"223","article-title":"Nervous system: Alzheimer's disease","volume-title":"Clinical Manual of Gerontological Nursing","author":"Strength","year":"1992"},{"issue":"3","key":"10.1002\/14651858.CD007578.pub2-BIB0275|cit275","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/503017","article-title":"An investigation of potential neurosurgical transmission of Creutzfeldt-Jakob disease: Challenges and lessons learned","volume":"27","author":"Stricof","year":"2006","journal-title":"Infection Control and Hospital Epidemiology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD007578.pub2-BIB0276|cit276","first-page":"s224","article-title":"Developing an administrative plan for transfusion medicine - A global perspective","volume":"45","author":"Sullivan","year":"2005","journal-title":"Transfusion"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD007578.pub2-BIB0277|cit277","doi-asserted-by":"crossref","first-page":"s13","DOI":"10.1053\/j.seminhematol.2006.02.005","article-title":"A Patient's Perspective on Hemophilia","volume":"43","author":"Sulser","year":"2006","journal-title":"Seminars in Hematology"},{"issue":"11","key":"10.1002\/14651858.CD007578.pub2-BIB0278|cit278","first-page":"2","article-title":"Failure to heed warnings on human tissue labels","volume":"36","author":"Tammelleo","year":"1996","journal-title":"Regan Report on Hospital Law"},{"issue":"8","key":"10.1002\/14651858.CD007578.pub2-BIB0279|cit279","first-page":"1447","article-title":"[Counseling families and patients with prion disease]","volume":"65","author":"Tamura","year":"2007","journal-title":"Nippon Rinsho [Japanese Journal of Clinical Medicine]"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0280|cit280","first-page":"i","article-title":"Preface","volume":"22","author":"Tien","year":"2007","journal-title":"Virologica Sinica"},{"issue":"5","key":"10.1002\/14651858.CD007578.pub2-BIB0281|cit281","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1046\/j.1365-2044.2002.26267.x","article-title":"Blood contamination of laryngeal mask airways and laryngoscopes - What do we tell our patients?","volume":"57","author":"Tordoff","year":"2002","journal-title":"Anaesthesia"},{"issue":"5","key":"10.1002\/14651858.CD007578.pub2-BIB0282|cit282","first-page":"969","article-title":"The precautionary principle: its benefits and risks","volume":"184","author":"Tubiana","year":"2000","journal-title":"Bulletin de l Academie Nationale de Medecine"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0283|cit283","first-page":"68","article-title":"The precautionary principle: advantages and risks","volume":"138","author":"Tubiana","year":"2001","journal-title":"Journal de Chirurgie"},{"issue":"4","key":"10.1002\/14651858.CD007578.pub2-BIB0284|cit284","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0886-3350(03)00150-0","article-title":"Creutzfeldt-Jakob disease and eye surgery - New disease, old disease","volume":"29","author":"Tullo","year":"2003","journal-title":"Journal of Cataract and Refractive Surgery"},{"issue":"7","key":"10.1002\/14651858.CD007578.pub2-BIB0285|cit285","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1442-9071.2006.01308.x","article-title":"Transplantation of ocular tissue from a donor with sporadic Creutzfeldt-Jakob disease","volume":"34","author":"Tullo","year":"2006","journal-title":"Clinical and Experimental Ophthalmology"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0286|cit286","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1097\/00001721-200306001-00015","article-title":"vCJD screening and its implications for transfusion--strategies for the future?","volume":"14 Suppl 1","author":"Turner","year":"2003","journal-title":"Blood Coagulation & Fibrinolysis"},{"issue":"34","key":"10.1002\/14651858.CD007578.pub2-BIB0287|cit287","first-page":"28","article-title":"Emerging concerns related to CJD","volume":"100","author":"Turner","year":"2004","journal-title":"Nursing Times Clinical"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0288|cit288","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2141.2008.07376.x","article-title":"An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products","volume":"144","author":"Turner","year":"2009","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0289|cit289","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1423-0410.1998.tb05464.x","article-title":"Donor selection: the exclusion of high risk donors?","volume":"74 Suppl 2","author":"Burg","year":"1998","journal-title":"Vox Sanguinis"},{"issue":"5","key":"10.1002\/14651858.CD007578.pub2-BIB0290|cit290","first-page":"565","article-title":"Creutzfeldt-Jakob disease latest unknown in struggle to restore faith in blood supply","volume":"155","author":"Vaughan","year":"1996","journal-title":"CMAJ"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0291|cit291","unstructured":"vCJD Clinical Governance Advisory Group Report of the vCJD Clinical Governance Advisory Group (http:\/\/www.dh.gov.uk\/en\/Publicationsandstatistics\/Publications\/PublicationsPolicyAndGuidance\/DH_073486) (accessed 17 December 2007)"},{"issue":"4","key":"10.1002\/14651858.CD007578.pub2-BIB0292|cit292","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/108107399126869","article-title":"Health communication and consumer behavior on meat in Belgium: From BSE until dioxin","volume":"4","author":"Verbeke","year":"1999","journal-title":"Journal of Health Communication"},{"issue":"9237","key":"10.1002\/14651858.CD007578.pub2-BIB0293|cit293","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S0140-6736(00)02785-9","article-title":"Variant Creutzfeldt-Jakob disease in UK children: A national surveillance study","volume":"356","author":"Verity","year":"2000","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD007578.pub2-BIB0294|cit294","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/adc.2004.071266","article-title":"No clinical evidence of hidden vCJD in UK children","volume":"91","author":"Verity","year":"2006","journal-title":"Archives of Disease in Childhood"},{"issue":"7","key":"10.1002\/14651858.CD007578.pub2-BIB0295|cit295","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1537-2995.2004.03400.x","article-title":"Long-term survival after blood transfusion: a population based study in the North of England","volume":"44","author":"Wallis","year":"2004","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0296|cit296","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ana.21294","article-title":"Risk factors for sporadic Creutzfeldt-Jakob disease","volume":"63","author":"Ward","year":"2008","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0297|cit297","first-page":"5","article-title":"An overview of the care issues for Creutzfeldt-Jakob disease","volume":"10","author":"Weller","year":"2003","journal-title":"European Journal of Palliative Care"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0298|cit298","unstructured":"WHO Expert Consultation Meeting Risk Perception and Communication Setting the agenda for the 5th Ministerial Conference on Environment and Health, 2009 www.euro.who.int\/Document\/Hms\/RiskPercep_Comms.pdf (accessed 18 March 2008) May 2006"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0299|cit299","unstructured":"WHO WHO guidelines on tissue infectivity distribution in transmissible spongiform encephalopathies www.who.int\/bloodproducts\/cs\/TSEPUBLISHEDREPORT.pdf (accessed 20 March 2008)"},{"issue":"12","key":"10.1002\/14651858.CD007578.pub2-BIB0300|cit300","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1751-0813.2000.tb10503.x","article-title":"The BSE inquiry and communication of risk","volume":"78","author":"Wilks","year":"2000","journal-title":"Australian Veterinary Journal"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0301|cit301","unstructured":"Willesee A All about my mother Good Weekend Magazine (The Age newspaper) 36 9"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0302|cit302","first-page":"59","article-title":"A policy analysis of major decisions relating to Creutzfeldt-Jakob disease and the blood supply","volume":"165","author":"Wilson","year":"2001","journal-title":"CMAJ"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0303|cit303","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/0950543042000193780","article-title":"Intersecting discourses: MMR vaccine and BSE","volume":"13","author":"Wilson","year":"2004","journal-title":"Science as Culture"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0304|cit304","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2458-4-1","article-title":"The reporting of theoretical health risks by the media: Canadian newspaper reporting of potential blood transmission of Creutzfeldt-Jakob disease","volume":"4","author":"Wilson","year":"2004","journal-title":"BMC Public Health"},{"issue":"7551","key":"10.1002\/14651858.CD007578.pub2-BIB0305|cit305","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1136\/bmj.332.7551.1164","article-title":"A new human genotype prone to variant Creutzfeldt Jakob disease","volume":"332","author":"Wilson","year":"2006","journal-title":"BMJ"},{"issue":"9552","key":"10.1002\/14651858.CD007578.pub2-BIB0306|cit306","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/S0140-6736(06)69835-8","article-title":"Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report","volume":"368","author":"Wroe","year":"2006","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD007578.pub2-BIB0307|cit307","first-page":"677","article-title":"Creutzfeldt-Jakob disease and nursing care","volume":"56","author":"Yamauchi","year":"2002","journal-title":"IRYO [Japanese Journal of National Medical Services]"},{"issue":"11","key":"10.1002\/14651858.CD007578.pub2-BIB0308|cit308","first-page":"637","article-title":"Introduction: A prospect of nursing and care of patients with Creutzfeldt-Jakob disease","volume":"56","author":"Yuasa","year":"2002","journal-title":"IRYO [Japanese Journal of National Medical Services]"},{"issue":"9","key":"10.1002\/14651858.CD007578.pub2-BIB0309|cit309","first-page":"447","article-title":"Human growth hormone and Creutzfeldt-Jakob disease","volume":"83","author":"Zekauskas","year":"1990","journal-title":"Oklahoma State Medical Association Journal"},{"issue":"7","key":"10.1002\/14651858.CD007578.pub2-BIB0310|cit310","first-page":"517","article-title":"Bovine spongiform encephalopathy and Creutzfeld-Jakob disease - official information from the government","volume":"17","author":"Anonymous","year":"1996","journal-title":"Revue de Medecine Interne"},{"issue":"9","key":"10.1002\/14651858.CD007578.pub2-BIB0311|cit311","first-page":"1082","article-title":"[Variants of Creutzfeldt Jacob disease. Opinion of the Working Group on Blood of the Federal Ministry for Health and Social Security]","volume":"48","author":"Anonymous","year":"2005","journal-title":"Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0312|cit312","first-page":"1082","article-title":"Variante Creutzfeldt-Jakob Krankheit","volume":"9","author":"Anonymous","year":"2005","journal-title":"Bundesgesundheitsbl - Gesundheitsforsch -Gesundheitsschutz"},{"issue":"5","key":"10.1002\/14651858.CD007578.pub2-BIB0313|cit313","first-page":"949","article-title":"Possible transmission of Creutzfeldt-Jakob disease via blood products - informing individuals with potential contamination","volume":"181","author":"Bastin","year":"1997","journal-title":"Bulletin de l Academie Nationale de Medecine"},{"issue":"21","key":"10.1002\/14651858.CD007578.pub2-BIB0314|cit314","first-page":"1533","article-title":"[Informing the transfused patient of the possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion]","volume":"33","author":"Boixiere","year":"2004","journal-title":"Presse Medicale"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0315|cit315","first-page":"101","article-title":"Legal obligation to inform the patient on the theoretical risk of CJD transmission by blood","volume":"11","author":"Boixiere","year":"2004","journal-title":"Transfusion Clinique et Biologique"},{"issue":"4","key":"10.1002\/14651858.CD007578.pub2-BIB0316|cit316","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3917\/spub.034.0379","article-title":"Development of the public health law: Valuable elements worth sharing","volume":"15","author":"Chambaud","year":"2003","journal-title":"Sante Publique"},{"issue":"4","key":"10.1002\/14651858.CD007578.pub2-BIB0317|cit317","first-page":"267","article-title":"Infectious risk prevention in gastrointestinal endoscopy","volume":"13","author":"Chapuis","year":"2006","journal-title":"Hepato-Gastro"},{"issue":"5-6","key":"10.1002\/14651858.CD007578.pub2-BIB0318|cit318","first-page":"472","article-title":"The precautionary principle, a new legal principle?","volume":"44","author":"Dubouis","year":"2001","journal-title":"Journal de Medecine Legale Droit Medical"},{"issue":"2414","key":"10.1002\/14651858.CD007578.pub2-BIB0319|cit319","first-page":"2196","article-title":"Mad cow disease news (103): Potential interhuman contaminations in Great Britain","volume":"60","author":"Nau","year":"2002","journal-title":"Medecine et Hygiene"},{"issue":"2465","key":"10.1002\/14651858.CD007578.pub2-BIB0320|cit320","first-page":"144","article-title":"Mad cow: The American night (1)","volume":"62","author":"Nau","year":"2004","journal-title":"Medecine et Hygiene"},{"issue":"31","key":"10.1002\/14651858.CD007578.pub2-BIB0321|cit321","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.53738\/REVMED.2005.1.31.2058","article-title":"Mad cow: Towards a first blood screening test","volume":"1","author":"Nau","year":"2005","journal-title":"Revue Medicale Suisse"},{"issue":"5-6","key":"10.1002\/14651858.CD007578.pub2-BIB0322|cit322","first-page":"464","article-title":"Creutzfeldt-Jakob's Disease: Health Safety and Ethical Considerations","volume":"44","author":"Proust","year":"2001","journal-title":"Journal de Medecine Legale Droit Medical"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0323|cit323","unstructured":"Quimper E Universite de Sherbrooke (Canada) 2006"},{"issue":"4","key":"10.1002\/14651858.CD007578.pub2-BIB0324|cit324","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF03163629","article-title":"Creutzfeldt-Jakob-disease: The Hanusch-Hospital experience","volume":"20","author":"Rigal","year":"2006","journal-title":"Spektrum der Augenheilkunde"},{"issue":"37","key":"10.1002\/14651858.CD007578.pub2-BIB0325|cit325","first-page":"4045","article-title":"[The National Board of Health and Welfare on Creutzfeldt-Jakob disease: physicians are to be notified about suspected cases]","volume":"97","author":"Tull","year":"2000","journal-title":"Lakartidningen"},{"issue":"47","key":"10.1002\/14651858.CD007578.pub2-BIB0326|cit326","first-page":"1613","article-title":"Relevant communication","volume":"134","author":"Roon","year":"1999","journal-title":"Pharmaceutisch Weekblad"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0327|cit327","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S0140-6736(09)60519-5","article-title":"Listening to patients with rare diseases","volume":"373","author":"Editorial","year":"2009","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD007578.pub2-BIB0328|cit328","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1176\/jnp.2007.19.4.428","article-title":"Does the presentation of Creutzfeldt-Jakob disease vary by age or presumed etiology? A meta-analysis of the past 10 years","volume":"19","author":"Appleby","year":"2007","journal-title":"Journal of Neuropsychiatry and Clinical Neurosciences"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0329|cit329","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-230-80185-1","volume-title":"Speaking for patients and carers. Health consumer groups and the policy process","author":"Baggott","year":"2005"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0330|cit330","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2934.2005.00449.x","article-title":"Care management of Creutzfeldt-Jakob disease within the United Kingdom","volume":"13","author":"Barnett","year":"2005","journal-title":"Journal of Nursing Management"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0331|cit331","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2288-9-59","article-title":"Methods for the synthesis of qualitative research: a critical review","volume":"9","author":"Barnett-Page","year":"2009","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0332|cit332","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/bmj.328.7432.118","article-title":"Recipients of blood or blood products 'at vCJD risk'","volume":"328","author":"Bird","year":"2004","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0333|cit333","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.0042-9007.2004.00380.x","article-title":"A review of general hepatitis C virus lookbacks in Canada","volume":"86","author":"Bowker","year":"2004","journal-title":"Vox Sanguinis"},{"issue":"3","key":"10.1002\/14651858.CD007578.pub2-BIB0334|cit334","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1212\/01.wnl.0000231528.65069.3f","article-title":"Iatrogenic Creutzfeldt-Jakob disease: the waning of an era","volume":"67","author":"Brown","year":"2006","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0335|cit335","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/bmj.38987.492014.94","article-title":"How to formulate research recommendations","volume":"333","author":"Brown","year":"2006","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0336|cit336","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/archpedi.161.2.125","article-title":"Results of a general hepatitis C lookback program for persons who received blood transfusions in neonatal intensive care between January 1975 and July 1992","volume":"161","author":"Cagle","year":"2007","journal-title":"Archive of Pediatric and Adolescent Medicine"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0337|cit337","unstructured":"Cegelka J Creutzfeldt Jakob disease: the psychological effect it has on caregivers PhD thesis. The Union Institute and University Graduate College. 2002"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0338|cit338","unstructured":"Creutzfeldt-Jakob Disease Founation Inc Creutzfeldt-Jakob disease and other prion diseases (www.cjdfoundation.org) (accessed 21 February 2008)"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0339|cit339","unstructured":"CJD Incidents Panel Management of possible exposure to CJD through medical procedures, Framework Document (www.hpa.org.uk\/infections\/topics_az\/cjd\/incidents_panel.htm) (accessed 12 February 2008) August 2005"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0340|cit340","unstructured":"CJD Support Network CJD and prion disease: an introduction and explanation Available from the CJD Support Network (www.cjdsupport.net) (accessed 18 February 2008) March 2007"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0341|cit341","unstructured":"CJD Surveillance Unit The different types of CJD (www.cjd.ed.ac.uk\/CJDtype\/cjdtype.htm#iatrogenic) (accessed 12 February 2008) 2002"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0342|cit342","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00520-002-0392-x","article-title":"Communication, information and support for adults with malignant cerebral glioma: a systematic literature review","volume":"11","author":"Davies","year":"2003","journal-title":"Supportive Care in Cancer"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0343|cit343","unstructured":"Australian Government Department of Health and Ageing Infection control guidelines for the prevention of transmission of infectious diseases in the health care setting. Part 4 Managing Infectious Diseases in the Health Care Setting. Chapter 31 Creutzfeldt-Jakob disease www.health.gov.au\/internet\/main\/publishing.nsf\/Content\/icg-guidelines-index.htm (accessed 28 July 2008) revised December 2007"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0344|cit344","unstructured":"Victorian Government Department of Human Services Report of the consensus workshop. Creutzfeldt-Jakob disease: preventing transmission in the health care setting. Implementing the Infection Control Guidelines www.dhs.vic.gov.au (accessed 5 February 2008)"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0345|cit345","unstructured":"Douglas MJ Campbell H Will RG Patients with new variant Creutzfeldt-Jakob disease and their families: care and information needs National CJD Surveillance Unit, UK. www.cjd.ed.ac.uk\/index.htm (accessed 18 June 2007) 1999"},{"issue":"4","key":"10.1002\/14651858.CD007578.pub2-BIB0346|cit346","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1200\/JCO.2005.03.0577","article-title":"Discussing bad news in the outpatient oncology clinic: rethinking current communication guidelines","volume":"24","author":"Eggly","year":"2006","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0347|cit347","unstructured":"EURODIS The Voice of 12,000 Patients: Experiences and Expectations of Rare Disease Patients on Diagnosis and Care in Europe. A report based on the EurordisCare2 and EurordisCare3 Surveys http:\/\/archive.eurordis.org\/article.php3?id_article=1296%3F (accessed 17 August 2010) 2009"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0348|cit348","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/jnnp.2007.122267","article-title":"Iatrogenic Creutzfeldt-Jakob disease 22 years after human growth hormone therapy: clinical and radiological features","volume":"79","author":"Furtner","year":"2008","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD007578.pub2-BIB0349|cit349","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jclinepi.2007.02.001","article-title":"Response to paper by Lang A, Edwards N, and Fleiszer A","volume":"60","author":"Green","year":"2007","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD007578.pub2-BIB0350|cit350","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/annonc\/mdi211","article-title":"Communicating prognosis in cancer care: a systematic review of the literature","volume":"16","author":"Hagerty","year":"2005","journal-title":"Annals of Oncology"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0351|cit351","first-page":"149","article-title":"A Canadian hospital-based HIV\/hepatitis C look-back notification program","volume":"157","author":"Heddle","year":"1997","journal-title":"CMAJ"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD007578.pub2-BIB0352|cit352","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1741-6892.2004.00442.x","article-title":"Implications of notifying donors and recipients","volume":"87","author":"Hewitt","year":"2004","journal-title":"Vox Sanguinis"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0353|cit353","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions The Cochrane Collaboration, 2008 Available from www.cochrane-handbook.org. [updated February 2008]","DOI":"10.1002\/9780470712184"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0354|cit354","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1086\/JCE200112209","article-title":"Comment: Limiting toxic information","volume":"12","author":"Howe","year":"2001","journal-title":"The Journal of Clinical Ethics"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0355|cit355","unstructured":"Health Protection Agency UK The epidemiology of infections among blood and tissue donors and recipients www.hpa.org.uk\/infections\/topics_az\/BIBD\/sur_tti.htm (accessed 11 January 2008) 2008"},{"issue":"4","key":"10.1002\/14651858.CD007578.pub2-BIB0356|cit356","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1369-7625.2009.00552.x","article-title":"What, if anything, is specific about having a rare disorder? Patients' judgements on being ill and being rare","volume":"12","author":"Huyard","year":"2009","journal-title":"Health Expectations"},{"issue":"6","key":"10.1002\/14651858.CD007578.pub2-BIB0357|cit357","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/intqhc\/mzn043","article-title":"Patients' and family members' experiences of open disclosure following adverse events","volume":"20","author":"Iedema","year":"2008","journal-title":"International Journal for Quality in Health Care"},{"issue":"6","key":"10.1002\/14651858.CD007578.pub2-BIB0358|cit358","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1001\/archpedi.1995.02170190090016","article-title":"The HIV information project for transfusion recipients a decade after transfusion","volume":"149","author":"King","year":"1995","journal-title":"Archives of Pediatric and Adolescent Medicine"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0359|cit359","first-page":"155","article-title":"Look-back notification: how do we assess effectiveness?","volume":"157","author":"King","year":"1997","journal-title":"CMAJ"},{"issue":"3","key":"10.1002\/14651858.CD007578.pub2-BIB0360|cit360","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1086\/505215","article-title":"Creutzfeldt-Jakob disease: a rare cause of dementia in elderly persons","volume":"43","author":"Knight","year":"2006","journal-title":"Clinical Infectious Diseases"},{"issue":"9","key":"10.1002\/14651858.CD007578.pub2-BIB0361|cit361","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1212\/01.WNL.0000160117.56690.B2","article-title":"Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australian, and Canada","volume":"64","author":"Ladogana","year":"2005","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD007578.pub2-BIB0362|cit362","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jclinepi.2007.01.005","article-title":"Empty systematic reviews: hidden perils and lessons learned","volume":"60","author":"Lang","year":"2007","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD007578.pub2-BIB0363|cit363","first-page":"288","article-title":"Evaluation of the notification of hepatitis C risk to children who received unscreened blood or blood products","volume":"4","author":"Langley","year":"2001","journal-title":"Communciable Diseases and Public Health"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0364|cit364","unstructured":"Leliopoulo C Wilkinson SM Fellowes D Does truth telling improve psychological distress of palliative care patients: a systematic review London: Royal Free and UCL Medical School, Department of Oncology, Marie Curie Palliative Care Research and Development Unit. 2001 1 20"},{"issue":"3","key":"10.1002\/14651858.CD007578.pub2-BIB0365|cit365","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.pec.2009.07.018","article-title":"Disclosing medical errors to patients: A challenge for health care professionals and institutions","volume":"76","author":"Levinson","year":"2009","journal-title":"Patient Education and Counseling"},{"issue":"3","key":"10.1002\/14651858.CD007578.pub2-BIB0366|cit366","article-title":"Methods of communicating a primary diagnosis of breast cancer to patients","author":"Lockhart","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"15","key":"10.1002\/14651858.CD007578.pub2-BIB0367|cit367","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1001\/archinte.164.15.1690","article-title":"Communicating with patients about medical errors: a review of the literature","volume":"164","author":"Mazor","year":"2004","journal-title":"Archives of Internal Medicine"},{"issue":"10","key":"10.1002\/14651858.CD007578.pub2-BIB0368|cit368","first-page":"27","article-title":"A case study: team support for a patient with CJD","volume":"4","author":"Meek","year":"1998 Nov","journal-title":"Community Nurse"},{"issue":"4","key":"10.1002\/14651858.CD007578.pub2-BIB0369|cit369","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1521\/aeap.15.5.309.23821","article-title":"HIV testing and counseling: test providers' experiences of best practices","volume":"15","author":"Myers","year":"2003","journal-title":"AIDS Education and Prevention"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0370|cit370","unstructured":"National Institute for Clinical Excellence Improving supportive and palliative care for adults with cancer London: National Institute for Clinical Excellence (NICE) 2004"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0371|cit371","unstructured":"National Institute for Health and Clinical Excellence Patient safety and reduction of risk of transmission of Creutzfeldt\u2013Jakob disease (CJD) via interventional procedures (www.nice.org.uk)"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0372|cit372","unstructured":"National Institute of Neurological Disorders and Stroke Creutzfeldt-Jakob disease fact sheet (www.ninds.nih.gov\/disorders\/cjd\/detail_cjd.htm) (accessed August 13 2008)"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0373|cit373","unstructured":"National Prion Clinic National Prion Clinic Factsheets - Prion diseases www.uclh.nhs.uk (accessed 14 January 2008)"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0374|cit374","unstructured":"National Prion Clinic National prion Clinic Factsheets - Acquired prion disease: iatrogenic Creutzfeldt-Jakob disease (www.uclh.nhs.uk) (accessed 14 January 2008)"},{"issue":"7","key":"10.1002\/14651858.CD007578.pub2-BIB0375|cit375","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1200\/JCO.2001.19.7.2049","article-title":"Breaking bad news about cancer: patients' preferences for communication","volume":"19","author":"Parker","year":"2001","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0376|cit376","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/1471-2458-6-278","article-title":"Human transmissible spongiform encephalopathies in eleven countries: diagnostic patterns across time, 1993-2002","volume":"6","author":"Pedro-Cuesta","year":"2006","journal-title":"BMC Public Health"},{"issue":"10","key":"10.1002\/14651858.CD007578.pub2-BIB0377|cit377","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1093\/brain\/awh249","article-title":"Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissable spongiform encephalopathies","volume":"127","author":"Pocchiari","year":"2004","journal-title":"Brain"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0378|cit378","unstructured":"Pollock M Creutzfeldt-Jakob disease surveillance in New Zealand. Eleventh Annual Report 1 January 2007 - 31 December 2007 The New Zealand Creutzfeldt-Jakob Registry 2007"},{"issue":"10","key":"10.1002\/14651858.CD007578.pub2-BIB0379|cit379","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1371\/journal.pmed.0030342","article-title":"Insights into the management of emerging infections: regulating variant Creutzfeldt-Jakob disease transfusion risk in the UK and the US","volume":"3","author":"Ponte","year":"2006","journal-title":"PLoS Medicine"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0380|cit380","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1423-0410.2003.00343.x","article-title":"Future counseling of donors and recipients of blood products concerning prion-related diseases","volume":"85","author":"Reesink","year":"2003","journal-title":"Vox Sanguinis"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0381|cit381","unstructured":"Ryan R Broclain D Horey D Oliver S Prictor M Hill S Cochrane Consumers and Communication Review Group Study Quality Guide www.latrobe.edu.au\/cochrane\/assets\/downloads\/StudyQualityGuide050307.pdf 2007"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0382|cit382","unstructured":"Ryan R Lowe D Hill S Mead C Evidence on strategies for notifying and supporting consumers following exposure to the risk of Creutzfeldt-Jakob disease (CJD) through medical treatment: a review of the evidence A report to the Department of Human Services, Victoria, Australia. http:\/\/www.health.vic.gov.au\/consumer\/pubs\/notifying_cjd.htm 2008"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0383|cit383","unstructured":"Ryan R Hill S Broclain D Horey D Oliver S Prictor M Cochrane Consumers and Communication Review Group. Study Design Guide July 2009"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0384|cit384","article-title":"Development of a patient-centred communication framework for people at risk of medically-acquired Creutzfeldt-Jakob disease (CJD): a systematic review and thematic synthesis","author":"Ryan","year":"[submitted, September 2010]","journal-title":"Medical Decision Making"},{"issue":"7","key":"10.1002\/14651858.CD007578.pub2-BIB0385|cit385","first-page":"829","article-title":"Blood recipients and CJD: to notify or not to notify, that is the question","volume":"159","author":"Sibbald","year":"1998","journal-title":"CMAJ"},{"issue":"6","key":"10.1002\/14651858.CD007578.pub2-BIB0386|cit386","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1086\/507030","article-title":"Methods to minimise the risks of Creutzfeldt-Jakob disease transmission by surgical procedures: where to set the standard?","volume":"43","author":"Sutton","year":"2006","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0387|cit387","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2288-8-45","article-title":"Methods for the thematic synthesis of qualitative research in systematic reviews","volume":"8","author":"Thomas","year":"2008","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0388|cit388","unstructured":"Transfusion Medicine Epidemiological Review Transfusion Medicine Epidemiological Review Available at: http:\/\/www.cjd.ed.ac.uk\/TMER\/TMER.htm, accessed December 13 2010 2010"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0389|cit389","unstructured":"Turner G Association of Directors of Social Services. CJD good practice guidelines for social services professionals Produced in collaboration with the CJD Support Network, UK June 2003"},{"issue":"2","key":"10.1002\/14651858.CD007578.pub2-BIB0390|cit390","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/08964289809596382","article-title":"Breaking bad news 2: what evidence is available to guide clinicians?","volume":"24","author":"Walsh","year":"1998","journal-title":"Behavioral Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007578.pub2-BIB0391|cit391","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1371\/journal.ppat.0020026","article-title":"The expanding universe of prion diseases","volume":"2","author":"Watts","year":"March 2006","journal-title":"PLoS Pathogens"},{"key":"10.1002\/14651858.CD007578.pub2-BIB0392|cit392","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/bmb\/66.1.255","article-title":"Acquired prion disease: iatrogenic CJD, variant CJD, kuru","volume":"66","author":"Will","year":"2003","journal-title":"British Medical Bulletin"},{"issue":"1","key":"10.1002\/14651858.CD007578.pub2-BIB0393|cit393","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.socscimed.2006.08.023","article-title":"Variant Creutzfeldt-Jakob disease and the Canadian blood system after the tainted blood tragedy","volume":"64","author":"Wilson","year":"2007","journal-title":"Social Science and Medicine"},{"issue":"11","key":"10.1002\/14651858.CD007578.pub2-BIB0394|cit394","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1089\/108729102761041092","article-title":"Desired elements of HIV testing services: test recipient perspectives","volume":"16","author":"Worthington","year":"2002","journal-title":"AIDS patient care and STDs"},{"issue":"8","key":"10.1002\/14651858.CD007578.pub2-BIB0395|cit395","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3949\/ccjm.65.8.412","article-title":"Hepatitis C update: implications of the blood transfusion 'lookback'","volume":"65","author":"Younossi","year":"1998","journal-title":"Cleveland Clinic Journal of Medicine"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD007578.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:33:51Z","timestamp":1789551231000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007578.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Consumers and Communication Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,3,16]]},"references-count":395,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007578.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,16]]}}}